88 related articles for article (PubMed ID: 18285770)
21. Selective binding of linear ubiquitin chains to NEMO in NF-kappaB activation.
Ikeda F; Rahighi S; Wakatsuki S; Dikic I
Adv Exp Med Biol; 2011; 691():107-14. PubMed ID: 21153314
[No Abstract] [Full Text] [Related]
22. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
[TBL] [Abstract][Full Text] [Related]
23. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
[TBL] [Abstract][Full Text] [Related]
24. Regulation of TNFRSF and innate immune signalling complexes by TRAFs and cIAPs.
Silke J; Brink R
Cell Death Differ; 2010 Jan; 17(1):35-45. PubMed ID: 19680262
[TBL] [Abstract][Full Text] [Related]
25. New perspectives in TNF-R1-induced NF-κB signaling.
Gentle IE; Silke J
Adv Exp Med Biol; 2011; 691():79-88. PubMed ID: 21153311
[No Abstract] [Full Text] [Related]
26. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
Boone DL; Turer EE; Lee EG; Ahmad RC; Wheeler MT; Tsui C; Hurley P; Chien M; Chai S; Hitotsumatsu O; McNally E; Pickart C; Ma A
Nat Immunol; 2004 Oct; 5(10):1052-60. PubMed ID: 15334086
[TBL] [Abstract][Full Text] [Related]
27. A20 inhibition of NFκB and inflammation: targeting E2:E3 ubiquitin enzyme complexes.
Shembade N; Harhaj E
Cell Cycle; 2010 Jul; 9(13):2481-2. PubMed ID: 20543575
[No Abstract] [Full Text] [Related]
28. A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production.
Nachbur U; Stafford CA; Bankovacki A; Zhan Y; Lindqvist LM; Fiil BK; Khakham Y; Ko HJ; Sandow JJ; Falk H; Holien JK; Chau D; Hildebrand J; Vince JE; Sharp PP; Webb AI; Jackman KA; Mühlen S; Kennedy CL; Lowes KN; Murphy JM; Gyrd-Hansen M; Parker MW; Hartland EL; Lew AM; Huang DC; Lessene G; Silke J
Nat Commun; 2015 Mar; 6():6442. PubMed ID: 25778803
[TBL] [Abstract][Full Text] [Related]
29. The RIP3-RIP1-NF-κB signaling axis is dispensable for necroptotic cells to elicit cross-priming of CD8
Ren J; Jia X; Zhao Y; Shi W; Lu J; Zhang Y; Wu J; Liang B; Wu R; Fu G; Han J
Cell Mol Immunol; 2017 Jul; 14(7):639-642. PubMed ID: 28626232
[No Abstract] [Full Text] [Related]
30. NF-κB-regulated ubiquitin-editing enzyme A20 paves the way for infection persistency.
Lim MCC; Maubach G; Naumann M
Cell Cycle; 2018; 17(1):3-4. PubMed ID: 29099284
[No Abstract] [Full Text] [Related]
31. The Role of Tissue-Specific Ubiquitin Ligases, RNF183, RNF186, RNF182 and RNF152, in Disease and Biological Function.
Okamoto T; Imaizumi K; Kaneko M
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486221
[TBL] [Abstract][Full Text] [Related]
32. CARP2 deficiency does not alter induction of NF-kappaB by TNFalpha.
Ahmed AU; Moulin M; Coumailleau F; Wong WW; Miasari M; Carter H; Silke J; Cohen-Tannoudji M; Vince JE; Vaux DL
Curr Biol; 2009 Jan; 19(1):R15-7; author reply R17-9. PubMed ID: 19138581
[No Abstract] [Full Text] [Related]
33. IKKα takes control of canonical NF-κB activation.
Pelzer C; Thome M
Nat Immunol; 2011 Aug; 12(9):815-6. PubMed ID: 21852778
[No Abstract] [Full Text] [Related]
34. [Ubiquitin ligases, which are involved in myelomagenesis].
Takeuchi T; Adachi Y; Furihata M; Ohtsuki Y
Nihon Rinsho; 2007 Jan; 65 Suppl 1():226-30. PubMed ID: 17474415
[No Abstract] [Full Text] [Related]
35. [Linear ubiquitination-mediated NF-κB regulation and its related diseases].
Tokunaga F
Seikagaku; 2013 Jun; 85(6):414-22. PubMed ID: 23875468
[No Abstract] [Full Text] [Related]
36. One more wheel for a processing machine.
Ben-Neriah Y
Cell Death Differ; 2015 Aug; 22(8):1235-6. PubMed ID: 26143747
[No Abstract] [Full Text] [Related]
37. Dissection of signaling in inflammation: three novel inflammatory regulators.
Berger T; Saunders ME; Mak TW
Cold Spring Harb Symp Quant Biol; 2013; 78():141-7. PubMed ID: 25028400
[TBL] [Abstract][Full Text] [Related]
38. The NLRP4-DTX4 axis: a key suppressor of TBK1 and innate antiviral signaling.
Charoenthongtrakul S; Gao L; Harhaj EW
Cell Mol Immunol; 2012 Nov; 9(6):431-3. PubMed ID: 23064103
[No Abstract] [Full Text] [Related]
39. The 'inflammatory' control of hematopoietic stem cells.
Rathinam C
Oncotarget; 2015 Aug; 6(24):19938-9. PubMed ID: 26119148
[No Abstract] [Full Text] [Related]
40. Cell death: Pathways for cross-priming.
Leavy O
Nat Rev Immunol; 2015 Dec; 15(12):725. PubMed ID: 26493941
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
